GAD1 and Ataxia: Of the IMCAs patients, 20% had GA, 2% had PCD, while 2% had anti-GAD ataxia, 1% had post-infectious cerebellitis, and <1% had opsoclonus-myoclonus syndrome (among those with total progressive ataxia).